| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.2 | 2e-05 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.33 | 4e-05 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.2 | 5e-05 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.86 | 0.0002 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0007 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.001 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |